Veterans returning from Iraq, Afghanistan may have increased risk of skin cancer
the ONA take:
A recent study has determined that soldiers serving in Iraq and Afghanistan face an increased risk of skin cancer. U.S. military deployments in the last decade have occurred largely at a more equatorial latitude, leading to greater sun exposure and cancer risk.
Vanderbilt dermatologist Jennifer Powers, M.D., and colleagues reviewed survey data obtained from 212 Middle East veterans regarding their sun exposure and use of sun protection. Apporximately 80% of those polled were recalling exposure history that occurred lover a year prior.
Respondents rated their use of sunscreen as either routine (13%) or characterized it as "sporadic" or "sometimes" (87%). Seventy-seven percent reported working 4+ hours a day in bright sun conditions and 63% reported at least one sunburn during deployment.
Only 23 percent of veterans polled reported that the military strongly cautioned them on the risks of skin cancer.
The researchers also reviewed the accessibility of sun protection gear for soldiers in the field, and study results indicate some correlation between available sun protection gear and frequency of use.
Study results were published in the Journal of Investigative Dermatology.
A recent study has determined that soldiers serving in Iraq and Afghanistan face an increased risk of skin cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|